Navigation Links
Benefits of Widespread Statin Use Outweigh Risks: Study
Date:5/17/2012

THURSDAY, May 17 (HealthDay News) -- Statins -- commonly used cholesterol-lowering drugs -- can significantly lower the risk for heart disease in people with no history of vascular disease, according to a new study.

Researchers from the University of Oxford in England found the medication reduced the risk of major heart-related problems, such as hearts attacks and strokes, in men and women of all ages with heart disease -- as well as those with no previous history of the condition -- by about 20 percent.

The benefits of widespread statin use outweigh any known side effects, said the study's authors, led by Colin Baigent, a professor in the clinical trial service unit and epidemiological studies unit at Oxford. The researchers said their findings should prompt a review of national and international guidelines on these drugs.

Current U.S. and European guidelines restrict statin use to people with at least a 20 percent risk of having a major vascular event within 10 years.

For their study, researchers examined 27 randomized trials involving 175,000 people. They investigated the effects of lowering LDL cholesterol with statins by grouping the patients into risk categories and comparing results. The researchers specifically explored whether statins were used and, if so, the intensity of the patients' therapy.

The study revealed that statins reduced the risk of serious vascular events by 21 percent in each of the five risk groups the researchers identified, including those at lowest risk for vascular disease.

The study was published online Wednesday in The Lancet.

The study's authors noted the benefits of statin therapy outweigh any known risks. This is true even for those with a five-year risk of a major vascular event lower than 10 percent, they said, meaning "people who would typically not be judged suitable for statin treatment."

The researchers said they found no evidence that statin therapy increased the prevalence of cancer or cancer-related deaths.

"Statins may produce small increased risks of hemorrhagic strokes and in diagnoses of diabetes, but the definite benefits of statins greatly outweigh these potential hazards," the authors said in a journal news release.

Half of all vascular events occur in people with no previous vascular history, they said.

The U.S. Food and Drug Administration recently required label changes on statin drugs to warn of rare thinking and memory problems associated with their use.

More information

The U.S. National Institutes of Health provides more information on statins.

-- Mary Elizabeth Dallas

SOURCE: The Lancet, news release, May 16, 2012


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Alzheimers Foundation of America Applauds Social Security for Speeding Disability Benefits for Early-Onset Alzheimers Disease
2. 1Dental.com Enhances Dental Plan Benefits With New Fee Schedule
3. Freedom Healthnet Affirms Affordable Private Health Insurance Benefits
4. Surgeon General with Microsoft HealthVault Expands Consumer Benefits for the My Family Health Portrait Offering
5. DSM Personalized Nutrition Webinar Explores Benefits of Nutrition for Employee Health
6. Greenway Medical Technologies Advances Patient-Provider Benefits
7. LG Electronics Expands Benefits of Healthcare HDTVs With New Compliance Ratings at HIMSS 2010
8. Studies Detail Possible Benefits of omega-3 Fatty Acids for Dogs With Arthritis
9. New study questions benefits of elective removal of ovaries during hysterectomy
10. Health Benefits Direct Announces Extension of Expiration of Rights Offering to March 26, 2010
11. Study evaluates costs and benefits of new chemotherapy drugs
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Benefits of Widespread Statin Use Outweigh Risks: Study
(Date:10/12/2017)... ... 2017 , ... Information about the technology: , Otomagnetics has ... prevention of a major side effect of chemotherapy in children. Cisplatin and carboplatin ... cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. Hearing ...
(Date:10/12/2017)... ... ... HMP , a leader in healthcare events and education, today announced that ... for ‘Best B-to-B Healthcare Website.’ Winners were announced during the Eddie & Ozzie Awards ... recognizes editorial and design excellence across a range of sectors. This year’s program included ...
(Date:10/12/2017)... ... October 12, 2017 , ... On Saturday, October 21, the ... – Miles by Moonlight to raise money for the American Heart Association Heart Walk. ... , Teams will work together to keep their treadmills moving for 5 hours. Treadmills ...
(Date:10/12/2017)... ... October 12, 2017 , ... Health Literacy Innovations ... literacy software tool, and the Cancer Patient Education Network (CPEN), an independent professional ... announce a new strategic alliance. , As CPEN’s strategic partner, HLI will ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... in wound care advancements to physician colleagues, skilled nursing facility medical directors and ... the Treacherous Waters of Wound Care." , "At many of these conferences we ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... Israel and NEW YORK , Sept. 27, ... with mobile health and big data solutions, today announced that its MyDario ... Please check your local TV listings for when The Dr. Oz Show ... ... season this month. ...
(Date:9/22/2017)... -- AVACEN Medical (AVACEN) announced that its CE-Marked AVACEN ... with the widespread pain associated with fibromyalgia in the ... Essex, England commented, "I had difficulty ... sleep at all, tremendous pain, with every movement sending ... AVACEN 100] enough, how this has and is helping ...
(Date:9/13/2017)... 13, 2017   OrthoAtlanta has been named the ... Host Committee (AFHC) for the 2018 College Football Playoff (CFP) ... at Mercedes-Benz Stadium in Atlanta, Georgia . ... "I,m In" campaign, participating in many activities leading up to, ... ...
Breaking Medicine Technology: